Paramount Bed Holdings Co (TSE:7817) Research & Development: 円0 Mil (TTM As of Sep. 2025)


TSE:7817 Paramount Bed Holdings Co Ltd TSE:7817
69 GF Score
Price 円3,515.00
GF Value 円2,907.43
! 6 Warning Signs
View Full Analysis

What is Paramount Bed Holdings Co Research & Development?

Paramount Bed Holdings Co TSE:7817 +0.14% 69 Research & Development is 円0 Mil as of Sep. 2025. GuruFocus rates TSE:7817 with a GF Score™ of 69/100 and a GF Value™ of 円2,907.43. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Paramount Bed Holdings Co's Research & Development for the three months ended in Sep. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was 円0 Mil.

Paramount Bed Holdings Co  (TSE:7817) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Paramount Bed Holdings Co Research & Development Related Terms

Paramount Bed Holdings Co Research & Development Historical Data

* Premium members only.

The historical data trend for Paramount Bed Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paramount Bed Holdings Co Research & Development Chart

Paramount Bed Holdings Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Paramount Bed Holdings Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7817
69GF Score
Paramount Bed Holdings Co Ltd TSE:7817
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paramount Bed Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Paramount Bed Holdings Co (TSE:7817) has a Research & Development of 円0 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Paramount Bed Holdings Co and its competitors.
Is Paramount Bed Holdings Co's Research & Development too high?
Paramount Bed Holdings Co's current Research & Development is 円0 Mil. Overall, Paramount Bed Holdings Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's Research & Development compare to ISRG and BDX?
Paramount Bed Holdings Co's Research & Development of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Paramount Bed Holdings Co and its competitors. Paramount Bed Holdings Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (TSE:7817) has a current Research & Development of 円0 Mil. The stock's GF Value™ is 円2,907.43, compared to a current price of 円3,515.00 — trading 20.9% above its estimated fair value. The current Research & Development is 円0 Mil. Paramount Bed Holdings Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Paramount Bed Holdings Co (TSE:7817), the current Research & Development is 円0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paramount Bed Holdings Co (TSE:7817) Overvalued in 2026?

Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued. The current stock price of 円3,515.00 is trading 20.9% above its estimated GF Value™ of 円2,907.43.

Key valuation signals for TSE:7817:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,907.43 vs. price of 円3,515.00 (20.9% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the TSE:7817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paramount Bed Holdings Co Business Description

Address 14-5, Higashisuna, 2-chome, Koto-ku, Tokyo, JPN, 136-8671
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
69GF Score

Get the complete analysis for TSE:7817

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,515.00
Price
円2,907.43
GF Value